Amunix Pharmaceuticals logo

Amunix Pharmaceuticals Funding & Investors

Amunix Inc. is a pharmaceutical company. The Company focuses on therapeutic drugs which offer an alternative to antibodies and small molecules. Amunix also concentrates on protein design and the discovery research process.

amunix.com

Total Amount Raised: $190,000,000

Amunix Pharmaceuticals Funding Rounds

  • Series B

    $117,000,000

    Series B Investors

    Polaris Partners
    Avidity Partners
    Bain Capital Life Sciences
    Omega Funds
    ArrowMark Partners
    Clough Capital Partners
    Venrock Healthcare Capital Partners
    CaaS Capital Management
    BlackRock
    Viking Global Investors
    Redmile Group
    Franklin Resources
    Frazier Management
    Longitude Capital
    Henderson Global Investors
    Casdin Capital
  • Series A

    $73,000,000

    Series A Investors

    Polaris Partners
    Redmile Group
    Two River
    Frazier Management
    Venrock
    Omega Funds
    Longitude Capital
    Delian Capital
    Casdin Capital
Funding info provided by Diffbot.